Evidence map›Paper›PMID 31802122›Full record

SynthesisThe international journal of neuropsychopharmacology2020

The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.

Konstantinos N Fountoulakis, Lakshmi N Yatham, Heinz Grunze, Eduard Vieta, Allan H Young, Pierre Blier, Mauricio Tohen, Siegfried Kasper, Hans Jurgen Moeller

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in The international journal of neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2022
    Pooled it
  3. The efficacy of adjunctiveThe British journal of psychiatry : the journal of mental science · 2025
    Trial
  4. Review
  5. Review
  6. Article
  7. Electroconvulsive therapy and autobiographical memory.Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Bipolar disorders: an update on critical aspects.The Lancet regional health. Europe · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 7 countries.

Konstantinos N Fountoulakis3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Lakshmi N YathamDepartment of Psychiatry, University of British Columbia, Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada.
Heinz GrunzePsychiatrie Schwäbisch Hall & Paracelsus Medical University, Nuremberg, Germany.
Eduard VietaHospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Allan H YoungCentre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Pierre BlierThe Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada.
Mauricio TohenDepartment of Psychiatry and Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM.
Siegfried KasperDepartment of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna.
Hans Jurgen MoellerPsychiatric Department, Ludwig Maximilians University, Munich, Germany.
Aristotle University of Thessaloniki · GRCentro de Investigación Biomédica en Red de Salud Mental · ESKing's College London · GBLudwig-Maximilians-Universität München · DEMedical University of Vienna · ATParacelsus Medizinische Privatuniversität · DEUniversity of British Columbia · CAUniversity of New Mexico · USUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResistant bipolar disorder is a major mental health problem related to significant disability and overall cost. The aim of the current study was to perform a systematic review of the literature concerning (1) the definition of treatment resistance in bipolar disorder, (2) its clinical and (3) neurobiological correlates, and (4) the evidence-based treatment options for treatment-resistant bipolar disorder and for eventually developing guidelines for the treatment of this condition. MATERIALS AND

methodsThe PRISMA method was used to identify all published papers relevant to the definition of treatment resistance in bipolar disorder and the associated evidence-based treatment options. The MEDLINE was searched to April 22, 2018.

resultsCriteria were developed for the identification of resistance in bipolar disorder concerning all phases. The search of the literature identified all published studies concerning treatment options. The data were classified according to strength, and separate guidelines regarding resistant acute mania, acute bipolar depression, and the maintenance phase were developed. DISCUSSION: The definition of resistance in bipolar disorder is by itself difficult due to the complexity of the clinical picture, course, and treatment options. The current guidelines are the first, to our knowledge, developed specifically for the treatment of resistant bipolar disorder patients, and they also include an operationalized definition of treatment resistance. They were based on a thorough and deep search of the literature and utilize as much as possible an evidence-based approach.

Indexed as

Drug ResistanceEvidence-Based MedicinePractice Guidelines as TopicAnticonvulsantsAntidepressive AgentsAntimanic AgentsAntipsychotic AgentsBipolar DisorderHumansAnticonvulsantsAntidepressive AgentsAntimanic AgentsAntipsychotic Agentsanticonvulsantsantidepressantsantipsychoticsbipolar disorderevidence-based guidelineslithiummaniamood stabilizersrefractorinesstreatmenttreatment resistant

Identifiers

PMID31802122
PMCPMC7177170
OpenAlexW2992518829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.